Sign inJoin waitlistJoin the waitlist

Yingda Xie

Associate Professor · Rutgers Health

Credentials: · · · · · ·

History

Rutgers Health
Present
Rutgers Health
Present

Infectious Disease
2012–2014
Internal Medicine
Oregon Health & Science University
2009–2012
University of Texas School of Medicine at San Antonio
2005–2009

Research

Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis
New England Journal of Medicine · 2017 · First of 26 authors · 119 citations
Linezolid Trough Concentrations Correlate with Mitochondrial Toxicity-Related Adverse Events in the Treatment of Chronic Extensively Drug-Resistant Tuberculosis
EBioMedicine · 2015 · 119 citations
Risk Factors and Outcomes of Hospitalized Patients With Severe Coronavirus Disease 2019 (COVID-19) and Secondary Bloodstream Infections: A Multicenter Case-Control Study
Clinical Infectious Diseases · 2021 · 71 citations

David Alland
8 papers
Scott Heysell
8 papers
RC
Ray Chen
7 papers
Susan Dorman
7 papers
CV
Christopher Vinnard
5 papers
Tania Thomas
5 papers
AL
Alfred Lardizabal
4 papers
Jerrold Ellner
4 papers
SH
Steven Holland
4 papers
CP
Charles Peloquin
3 papers
CP
Claire Park
3 papers
DE
David Elson
3 papers · 3 as a resident

Grants

Transmission Links and Clinical Spectrum of Exhaled Mycobacterium Tuberculosis
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $2M · Rutgers Biomedical and Health Sciences
2025–2030
Development of a Highly-Multiplexed CRISPR-Based TB Drug Susceptibility Test
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $2.2M · Rutgers Biomedical and Health Sciences
2024–2029
Imaging Signatures of Early Tuberculosis
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $2M · Rutgers Biomedical and Health Sciences
2023–2028
[R21] Integrated Computer-Aided, Point-of-Care Ultrasound for Tuberculosis Screening
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $412.7K · Rutgers Biomedical and Health Sciences
2022–2025

Clinical trials

Oral Rinse to Reduced Expelled Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) During COVID-19 Infection
Principal investigator · Completed · Early phase 1
Rutgers, The State University of New Jersey
2021–2022